COVID-19 drug development : : recent advances, new perspectives and applications / / Arli Aditya Parikesit, editor.
COVID-19 is a rampant worldwide problem. It is caused by the SARS-CoV-2 virus and is manifest in different variants. The Delta variant compromised existing therapeutic and preventive options for this disease and is beginning to be replaced by the Omicron variant. Through pharmaceutical biotechnology...
Saved in:
| TeilnehmendeR: | |
|---|---|
| Place / Publishing House: | London : : IntechOpen,, 2022. |
| Year of Publication: | 2022 |
| Language: | English |
| Physical Description: | 1 online resource (166 pages) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- 1. Introductory Chapter: Current Perspective of COVID-19 Drugs 22
- 2. Pluralism Medical Treatment, Prevention, and Control of COVID-19 Infection and Its Long-Sufferings among the Older Adults in the Northeast of Thailand from 2019 to 2022 142
- 3. Baricitinib in the Treatment of COVID-19 53
- 4. New Perspective and Applications of Homeopathy in Treating COVID-19 Symptoms 28
- 5. Treatments for the Infection by SARS-CoV-2 49
- 6. Inclusive Review on Existing Treatment and Management Modalities for COVID-19 39
- 7. COVID-19: From Pathophysiology to Treatment 35
- 8. COVID-19 Drug Development: Role of Drug Repurposing 16.